Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Email Alerts

Investor FAQs | Online Investor Kit | Email Alerts | Contact Information
You may automatically receive Charles River Laboratories International, Inc. financial information by email. To choose your options for email notification, please enter your email address below and click Submit. The next page will display a menu of options.

To change your email options at any time, re-enter your email address and click Submit, then adjust your form entries.

Enter your email address here:

Stock Quote

CRL (common)
Price
$109.34
Change (%)
+ 3.71 (3.51%)
Volume
390,653
Exchange
NYSE
Data as of 02/23/18 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)